Symposia: Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Fundamental Science, MDS, Lymphoid Leukemias, ALL, Translational Research, Assays, CHIP, Clinical Research, Bioinformatics, Genomics, Chronic Myeloid Malignancies, Hematopoiesis, Diversity, Equity, and Inclusion (DEI), Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Natural Killer (NK) Cell Therapies, Pathogenesis, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Fundamental Science, MDS, Lymphoid Leukemias, ALL, Translational Research, Assays, CHIP, Clinical Research, Bioinformatics, Genomics, Chronic Myeloid Malignancies, Hematopoiesis, Diversity, Equity, and Inclusion (DEI), Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Natural Killer (NK) Cell Therapies, Pathogenesis, Omics technologies
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Seaport Ballroom ABCD
(Manchester Grand Hyatt San Diego)
Moderators:
Ing Soo Tiong, FRACP, FRCPA, MPhil, ARRAY(0xeb236a4)
and
Brent Ferrell Jr., MD, Vanderbilt University School of Medicine
Disclosures:
Tiong: Novartis: Speakers Bureau; Jazz: Honoraria; Pfizer: Speakers Bureau. Ferrell: Novartis: Research Funding.
4:15 PM
4:30 PM
4:45 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH